Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study

BACKGROUND: We have previously demonstrated that high tumor tissue levels of TIMP-1 are associated with no or limited clinical benefit from chemotherapy with CMF and anthracyclines in metastatic breast cancer patients. Here, we extend our investigations to the adjuvant setting studying outcome after...

Descripción completa

Detalles Bibliográficos
Autores principales: Schrohl, Anne-Sofie, Look, Maxime P, Meijer-van Gelder, Marion E, Foekens, John A, Brünner, Nils
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754488/
https://www.ncbi.nlm.nih.gov/pubmed/19744322
http://dx.doi.org/10.1186/1471-2407-9-322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754488/
https://www.ncbi.nlm.nih.gov/pubmed/19744322
http://dx.doi.org/10.1186/1471-2407-9-322

Ejemplares similares